The Methodist Hospital Research Institute – FDA 483, Feb 13, 2026
The Methodist Hospital Research Institute, a PET drug manufacturer in Houston, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate oversight of production operations leading to data integrity concerns with electronic instrumentation and a failure to review original electronic data. The firm also failed to follow written quality assurance procedures regarding environmental monitoring excursions and lacked adequate production and process controls for sanitization. Additionally, issues with equipment cleaning and maintenance were noted, potentially affecting product sterility.
ID · efc9d77e-81b5-4c13-9794-a458bb575b0b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.